COVID-19 vaccinations have begun in the U.S., with a New York City nurse on Monday becoming the first recipient outside of clinical trial patients. But plenty of Americans remain skeptical, in part due to perceptions of undue political pressures.
Axios Re:Cap digs into the process, politics and science of COVID-19 vaccinations with Margaret Hamburg, who led the FDA between 2009 and 2015.
